Merck & Co Inc. (MRK) News Headlines

▮ More

Date

Headline

1/23/2020 8:05:38 AM Merck : Canada Oks KEYTRUDA As First-Line Treatment For Advanced RCC

1/23/2020 7:34:00 AM Merck Says Health Canada Approves KEYTRUDA As First-Line Treatment For Patients With Advanced Renal Cell Carcinoma

1/20/2020 2:38:28 AM AstraZeneca: FDA's ODD For Imfinzi, Tremelimumab; Priority Review For Lynparza

1/14/2020 1:42:38 AM Just - Evotec Grants MSD Access To J.POD(R) Facility - Quick Facts

1/14/2020 1:17:57 AM Just - Evotec Biologics Expands Collaboration With MSD

1/13/2020 2:30:28 AM AZN : Lynparza-bevacizumab Granted Priority Review In US For Ovarian Cancer

1/8/2020 8:47:05 PM FDA Nod For MRK, All Eyes On AGTC, ACTION Boosts APLT

1/6/2020 8:45:51 PM LIFE Gets A Boost With Kyorin Deal, XERS Up 20% After-Hrs, ITCI On Watch

12/31/2019 2:58:59 AM Biotech Stocks Facing FDA Decision In January 2020

12/30/2019 10:30:51 PM ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed

12/30/2019 2:27:10 AM AstraZeneca: Lynparza Approved In US For Pancreatic Cancer - Quick Facts

12/20/2019 12:58:41 PM FDA Approves Ervebo Vaccine For Prevention Of Ebola Virus Disease

12/20/2019 6:02:54 AM FDA Grants Approval For Merck's Ebola Vaccine Ervebo - Quick Facts

12/17/2019 9:29:01 PM AstraZeneca Says FDA Panel Backs Lynparza Use For Pancreatic Cancer

12/9/2019 9:04:04 AM Merck To Acquire ArQule For $20/share In Cash - Quick Facts

12/2/2019 8:16:23 AM Seattle Genetics, Astellas, Merck To Evaluate Enfortumab Vedotin Plus KEYTRUDA

12/2/2019 8:05:08 AM Seattle Genetics, Astellas Pharma Announce Clinical Collaboration Agreement With Merck

11/27/2019 9:03:58 AM What's Up With Merck Stock (MRK)?

11/18/2019 7:02:30 AM Merck: Ontario And Quebec Provide Reimbursement For HIV Therapies PIFELTRO And DELSTRIGO

11/14/2019 2:33:28 AM AZN:FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type1